首页> 外国专利> Recombinant plasmid DNA Per-TB4GyrA-AcSer, encoding the serine acetyltransferase, the ability of IN VIVO acetylated N-terminal serine Desacetylthymosin BETA 4 and the hybrid protein capable of autocatalytic cleavage with formation Thymosin Beta 4 HUMAN STRAIN Eschrichia coli C3030 / pER-TB4GyRA-AcSer PRODUCER These proteins and methods for producing genetically engineered thymosin Beta 4 HUMAN

Recombinant plasmid DNA Per-TB4GyrA-AcSer, encoding the serine acetyltransferase, the ability of IN VIVO acetylated N-terminal serine Desacetylthymosin BETA 4 and the hybrid protein capable of autocatalytic cleavage with formation Thymosin Beta 4 HUMAN STRAIN Eschrichia coli C3030 / pER-TB4GyRA-AcSer PRODUCER These proteins and methods for producing genetically engineered thymosin Beta 4 HUMAN

机译:重组质粒DNA Per-TB4GyrA-AcSer,编码丝氨酸乙酰基转移酶,IN VIVO乙酰化的N端丝氨酸脱乙酰胸腺素BETA 4的能力以及能够自催化裂解胸腺素Beta 4的人杂种蛋白AcSer生产商这些蛋白质和生产基因工程胸腺素β4人类的方法

摘要

1. A recombinant plasmid DNA pER - TB4GyrA - AcSer, containing polycistronic structure for simultaneous biosynthesis of two proteins - a fusion polypeptide containing thymosin β4 man and intein, and the enzyme of E.coli - serine acetyltransferase in cells of Escherichia col; NdeI / SapI - a fragment of the plasmid DNA pTWIN-1; NdeI / SapI - DNA fragment containing adapted to these sites gene sequence of recombinant human thymosin β4 and comprising, as a genetic marker β-lactamase gene that determines the stability of the transformed plasmid pER - TB4GyrA - AcSer E.coli cells to penicillin antibiotics; unique restriction endonuclease recognition sites located at a distance next to the left from the site BamHI - Pstl - 575 bp, NdeI -: 1493 bp, XbaI - 1532 bp, EcoRV - 3565 bp, HpaI - 3621 p.o.2. Escherichia coli Strain S3030 / pER - TB4GyrA - AcSer, producing a fusion polypeptide comprising a human β4 Desacetylthymosin and intein and serine acetyltransferase obtained by transforming Escherichia coli cells of the strain S3030 recombinant DNA plasmid pER - TB4GyrA - AcSer of claim 1.3.. A method for producing recombinant thymosin β4 human comprising transformation of strain Escherichia coli S3030 plasmid DNA pER - TB4GyrA -. AcSer, according to claim 1, culturing the producing strain Escherichia coli S3030 / pER - TB4GyrA -. AcSer according to claim 2, separation TB4GyrA fusion protein in the soluble form following cell disruption using ultrasonic disintegrator in a buffer solution (50 mM Tris / HCl, 10 mM EDTA, 1 mM PMSF), adsorbing the fusion protein to kolonkes chitinous sorbent (NEB, England), inducing its autocatalytic cleavage washing chitin sorbent buffer solution containing balanced in a buffer containing
机译:1.一种重组质粒DNA pER-TB4GyrA-AcSer,其具有多顺反子结构,用于同时生物合成两种蛋白质-包含胸腺素β4man和intein的融合多肽,以及大肠杆菌中的酶-丝氨酸乙酰转移酶。 NdeI / SapI-质粒DNA pTWIN-1的片段; NdeI / SapI-DNA片段,其含有适应于重组人胸腺素β4的这些位点基因序列的DNA片段,并且包含作为遗传标记的β-内酰胺酶基因,其确定了转化的质粒pER-TB4GyrA-AcSer大肠杆菌细胞对青霉素抗生素的稳定性;唯一限制性核酸内切酶识别位点,位于位点BamHI-Pstl-575 bp,NdeI-:1493 bp,XbaI-1532 bp,EcoRV-3565 bp,HpaI-3621 p.o.大肠杆菌菌株S3030 / pER-TB4GyrA-AcSer,产生包含人β4去乙酰胸腺素和内含肽和丝氨酸乙酰基转移酶的融合多肽,该融合多肽是通过转化权利要求1.3的S3030重组DNA质粒pER-TB4GyrA-AcSer的大肠杆菌细胞而获得的。用于生产重组胸腺素β4人的方法,其包括转化菌株S3030质粒DNA pER-TB4GyrA-。 2.根据权利要求1所述的AcSer,培养所述生产菌株大肠杆菌S3030 / pER-TB4GyrA-。 3.根据权利要求2所述的AcSer,其在缓冲液(50mM Tris / HCl,10mM EDTA,1mM PMSF)中使用超声崩解剂破坏细胞后,以可溶形式分离TB4GyrA融合蛋白,将融合蛋白吸附到kolonkes几丁质吸附剂(NEB)上。 (英国),诱导其自动催化裂解洗涤含有几丁质吸附剂的缓冲液,并在含有

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号